Cohance Lifesciences Market Cap

Cohance Lifesciences has a market cap or net worth of 367.38 billion as of July 1, 2025. Its market cap has increased by 114.80% in one year.

Market Cap

367.38B

Enterprise Value

368.81B

Revenue

11.98B

Ranking

n/a

PE Ratio

91.89

Stock Price

960.30

Market Cap Chart

Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 367.38B, an increase of 1,089,884.35%. That is a compound annual growth rate of 474.93%.

Market Cap History

Date	Market Cap	% Change
Jul 1, 2025	367.38B	26.73%
Dec 31, 2024	289.89B	57.55%
Dec 29, 2023	184.00B	46.05%
Dec 30, 2022	125.98B	0.33%
Dec 31, 2021	125.56B	9.05%
Dec 31, 2020	115.14B	341,510.23%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,049.12B
Divi's Laboratories	1,767.49B
Cipla	1,213.50B
Apollo Hospitals Enterprise	1,050.85B
Zydus Lifesciences	987.92B
Mankind Pharma	963.06B
Aurobindo Pharma	651.08B
Fortis Healthcare	591.89B

Market Cap Rankings